Ulipristal Acetate
醋酸乌利司他
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameUlipristal Acetate
Drug Alias Name +[18]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[15]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2009/05/15
Country/Territory +[26]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHra Pharma, Sa
China Registration ClassN/A
Develop Information
Active CompaniesAska Pharmaceutical Co LtdLaboratoire Hra-PharmaManchester University Nhs Foundation Trust +[7]
Inactive CompaniesHra PharmaUtah State UniversityGedeon Richter +[19]
Active Indications
Inactive Indications +[13]